Institutional Ownership
Lexaria Bioscience Corp
CUSIP 52886N406COM NEWLEXXQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
9.5%
Max % of class reported
Institutional Holders
25
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Nov 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2024 | Invenomic Capital Management LP | 13G/A | 4.7% | 567.6K | SEC |
| 2 | Feb 14, 2024 | Invenomic Capital Management LP | 13G/A | 7.1% | 732.0K | SEC |
| 3 | Feb 10, 2023 | Invenomic Capital Management LP | 13G/A | 8.0% | 473.1K | SEC |
| 4 | Feb 14, 2022 | Invenomic Capital Management LP | 13G | 6.0% | 359.1K | SEC |
| 5 | Feb 14, 2022 | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 2.6% | 159.0K | SEC |
| 6 | Feb 24, 2021 | Bunka Christopher | 13D/A | 9.5% | 489.5K | SEC |
| 7 | Jan 20, 2021 | L1 Capital Global Opportunities Master Fund, Ltd. | 13G | 5.6% | 285.7K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Invenomic Capital Management LP | 442.3K | $345.0K |
| 2 | Geode Capital Management, LLC | 294.2K | $229.5K |
| 3 | Toronto Dominion Bank | 140.0K | $109.3K |
| 4 | Ubs Group AG | 52.7K | $41.1K |
| 5 | State Street Corp | 39.3K | $30.7K |
| 6 | Blackrock, Inc. | 27.4K | $21.4K |
| 7 | Xtx Topco Ltd | 25.1K | $19.6K |
| 8 | Krilogy Financial LLC | 19.7K | $19.4K |
| 9 | Vontobel Holding Ltd. | 23.0K | $17.9K |
| 10 | Northern Trust Corp | 18.4K | $14.3K |